Endonovo Therapeutics Inc (ENDV)

[Biotech_Tradez]

How about the fact that expanding the label requires clinical studies? You simply do not ask for a new label unless you provide clinical data. Dollar for dollar, conditions without treatments like brain injury, stroke, MI, are blockbuster indications when compared with diseases where we are simply a better mouse trap. Make sense?

In regard to opioiods, they are marketing to reduce use of opioids following surgery looks like for plastic surgery and following C-sections.

Generating sales is going to take time, they are not going to go from acquiring the technology at the end of last year to generating $10 million in sales in the first six months. Especially, not when this technology had been placed on the shelf for years. If you cannot understand that you should seriously consider moving on or doing some research and bringing your expectations back to reality.